Biochemistry · 2008 · 79 citations · 23 references
PharmacyMedicinal ChemistryPharmacologyCancer PharmacologyDrug DesignDrug DiscoveryGenitourinary Cancer PharmacotherapyPeptidomimetic DesignProstate CancerProstate DisordersCell InternalizationCellular Internalization PathwaysProstate-specific Antigen - Targeted TherapyPsma-targeted Therapy
The mode of inhibition for phosphoramidate peptidomimetic inhibitors of prostate-specific membrane antigen was determined by inhibition reversibility experiments. The results revealed that these inhibitors can be classified into three types: pseudoirreversible (compounds 1-3), moderately reversible (compounds 4-9), and rapidly reversible inhibitors (compounds 10 and 11). Representative compounds from each class were further evaluated for their ability to induce cellular internalization of PSMA. Results from these experiments revealed that the pseudoirreversible inhibitor 1 induced the greatest PSMA internalization. The discovery of pseudoirreversible PSMA inhibitors is expected to provide a new avenue of investigation and therapeutic applications for prostate cancer and neurological disorders.
23
LNCaP model of human prostatic carcinoma.
Julius S. Horoszewicz, Susan S. Leong, Elzbieta Kawinski et al. · PubMed · 1983 · 1.8K citations
Medicine, Cancer Biology, Oncology +15
Neil H. Bander, Matthew I. Milowsky, David M. Nanus et al. · Journal of Clinical Oncology · 2005 · 508 citations
Medicine, Oncology, Pharmacokinetics +17
Prostate-specific membrane antigen is produced in tumor-associated neovasculature.
Sam S. Chang, Denise S. O’Keefe, Dean J. Bacich et al. · PubMed · 1999 · 464 citations
Constitutive and antibody-induced internalization of prostate-specific membrane antigen.
He Liu, A K Rajasekaran, P. Moy et al. · PubMed · 1998 · 448 citations